Dementia (Hanif) Flashcards

1
Q

What is the ability to restore and retrieve information?

  • Three systems?
A

Memory

  • Sensory memory
  • Short-term memory
  • Long term memory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A. Receives information from the sensory memory; information can stay here for 15-20 seconds

B. Receives information through the 5 senses (certain people have different strengths) and passes that information on to short term memory

C. Recalls information gathered over time - can stay here for a few days to a life time; used to process information

A

A. Short-term memory

B. Sensory memory

C. Long term memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dementia symptoms in the Mildly Cognitive Impaired:

  • Impaired ________ to time/place (forgetting conversations, misplacing items, forgetting names, loss of conversational skills)
  • Impaired ______
  • Loss of _____ or inability to perform hobbies or chores, eg. telephone, cooking, bills, finances
  • Alterations in ____/_____ (subtle change in interpersonal relations
  • New onset ___/___/___
A
  • orientation
  • judgement
  • interest
  • mood/behavior
  • anxiety/depression/paranoia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Alzheimer’s disease:

  • 3 causative genes have been associated with **AD, familial: ?
  • ** 1 genetic risk factor? (this increases a person’s risk of developing the disease, but people who develop AD may not have this allele)

Early onset familial AD caused by any one of a number of different single gene mutations on: ?

A
  • APP, PSEN1, PSEN2
  • APOEe4 allele

Chromosomes 21, 14, 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do mutations on chromosome 21 cause?

  • chromosome 14?
  • chromosome 1?
A

The formation of abnormal amyloid percursor protein (APP)

14: abnormal presenilin 1

1: abnormal persenilin 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Some causes of dementia:

  • _____: alzheimers, frontotemporal, DLB, Parkinsons, PSP, HD, WD, CJD
  • _____: multi-infarct, Binswanger’s CADASIL
  • _____: MS, vasculitis
  • _____: syphilis, lyme, HIV, other viral/fungal
  • _____: primary, metastatic, paraneoplastic
  • _____; hydrocephalus (NPH), trauma, concussions, chronic traumatic leukoencephalopathy
A
  • Primary neurodegenerative disorders
  • Vascular
  • Inflammatory
  • Infectious
  • Cancers
  • Other/physical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnosis?

  • Affects as many as 4 million Americans
  • Nearly 50% of all people age 85+ may have symptoms
  • Likely to affect more than 14.3 million americans by 2050; 1/10 people over 65 is affected
  • Degenerative brain disorder leading to progressive loss of memory and other cognitive functions
  • Most common form of dementia - changes in personality, behavior, judgement; loss of activities of daily living skills
  • RF: advanced age, FH,
A

Alzheimer’s Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Alzheimer’s disease:

  • In the mild stage - have _____ memory loss and forgetfulness; difficulty finding specific words; ______ deficits; MMSE of ?
  • In the moderate stage - short term memory is severely _____, less complex language, impaired ____, decreased _______, MMSE of ?
  • In the severe stage - _____ severely impaired, ____, recall becomes impossible, language may become restricted leading to ____, MMSE of ?
A
  • Mild - short term, executive functioning, 20-24
  • Moderate - restricted, insight, visuospatial ability and orientation, 11-19
  • Severe - attention, apraxia, mutism, less than or equal to 10
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnostic criteria for what?

  • Development of multiple cognitive deficits manifested by:
    • memory impairment
    • 1+ of the following: aphasia, apraxia, agnosia, disturbance in executive functioning
  • Significant impairment in social or occupational functioning representing a significant decline from a previous level of functioning
  • Gradual onset and progressive cognitive decline
A

Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What besides history, physical, lab tests, can be performed to aid in the diagnosis of Alzheimer’s disease?

A
  • Mental status examination
  • MMSE or MOCA (evaluates - registration, recall, visuospatial skills, calculation, abstract reasoning)
  • Brain Scans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

________ is an important neurotransmitter in areas of the brain involved in memory formation - what are these areas?

  • this decreases early in AD in the basal forebrain and correlates with the impairment of memory
  • Increases in this may benefit cognitive symptoms
    • reduced activity of what enzyme?
    • reduced number of ____ neurons
    • selective loss of certain nicotinic receptor subtypes
A

Acetylcholine - hippocampus, cerebral cortex, amygdala

  • choline acetyltransferase
  • cholinergic neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AD:

  • Presynaptic ____ receptors modulate the release of multiple neurotransmitters (memory, mood) - what are they?
    • Blocking these IMPAIRS COGNITION
    • Stimulating these IMPROVES MEMORY
A
  • Nicotinic
    • ACh, glutamate, serotonin, norepinephrine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the anatomic abnormalities seen of the brain with Alzheimer’s disease?

What abnormalities are seen under the microscope?

A
  • Pronounced atrophy, cerebral atrophy - ventricular dilation resulting from loss of cortex [hydrocephalus ex vacuo]
  • in neuropil see fragmentation of neurites = senile plaques (may contain astrocytes, microglia)
  • neurofibrillary tangle - commonly found in pyramidal cells of the hippocampus and cerebral cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AD:

Using fMRI to see where the brain fires when it is performing an activation task - subjects try to memorize a series of faces shown to them - what did this show?

*** THE EARLIEST DEFICIT - a PHYSIOLOGIC LESION

A

Decreased activation in the hippocampus for the AD patients - depicts a functional deficit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some treatment options for AD?

  • ____ - for treatment of mild to moderate AD
  • ____ - for behavioral symptoms
  • ____ - ?
  • ____ - 5 to 20mg/day, antagonizes NMDA receptors
  • ____ - antioxidant, 1000 U bid
  • Potential prevention: NSAIDs, HMG-CoA reductase inhibitors, red wine, smoking cessation, aerobic exercise
A
  • Cholinesterase inhibitors
  • Antipsychotics, antidepressants
  • Estrogen replacement therapy
  • Namenda (memantine)
  • Vitamin E
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

FYI:

  • Sx inconsistent with AD: sudden onset, FND, seizures early in course of illness, abnormal gait/coordination, preserved memory
  • Signs atypical for AD: dominant non-memory sx, prominent behavioral sx, early parkinsonism, early prominence of bulbar/brainstem signs; unexplained motor/reflex asymmetries, UMN signs, LMN signs
A
17
Q

Diagnosis?

  • Triad of dementia, gait, apraxia (magnetic gait), urinary incontinence
  • Clinical diagnosis, imaging + spinal tap
  • Tx. large volume spinal taps and shunt

What is the order of improvement?

A

Normal Pressure Hydrocephalus

  • gait, memory, incontinence
18
Q

These are examples of what type of dementia?

  • Pick’s disease
  • Dementia lacking distinctive histopathological features
  • Progressive subcortical gliosis
  • ALS-dementia, MND-dementia
  • Disinhibition-dementia-Parkinsonism-amyotrophy
A

Frontotemporal dementias

19
Q

Diagnosis?

  • Prominent early language impairment - echolalia, stereotypy, progressive reduction of speech
  • Prominent behavioral deficits (loss of drive, interests, mental rigidity, social impropriety, disinhibition, impulsivity, distractibility, hyperorality, stereotyped behaviors)
  • Early depression, anxiety, somatization, aspontaneity, indifference
  • relative preservation of praxis and visuospatial skills - memory intact or relatively well preserved
  • Brain imaging: predominant frontal and/or anterior temporal abnormality
A

Frontotemporal Dementia

20
Q

Diagnosis?

  • Onset >60 year, F>M
  • Personality changes - apathy, abulia, frontal release signs (frontal lobe inv)
  • Aphasia (temporal lobe inv)
  • Dementia (sparing praxis and visiospatial function)
  • Imaging: atrophy of the frontal and temporal lobes with sparing of the posterior 1/3rd of superior temporal gyrus
  • Pathology: pick’s bodies (argyrophillic, intracytoplasmic inclusions) and ballooned neurons
A

Pick’s disease

21
Q

What are the characteristic histologic changes in Pick’s disease?

A
  • Spherical inclusions in neurons of the cerebral cortex, basal ganglia, brainstem : Pick bodies
22
Q

Diagnosis?

  • Progressive cognitive decline affecting function - frontal subcortical visual dysfunction may be prominent
  • Core features: fluctuations in cognition, visual hallucinations, parkinsonism
  • Supportive features: falling, syncope, LOC, neuroleptic sensitivity, delusions, other hallucinations
    • ​Has to have dementia + 1+ hallmarks
  • Nigral pathology and eosinophillic cytoplasmic inclusions
A

Lewy-body Spectrum Pathology

23
Q

Diagnosis?

  • Onset >40, M>F
  • Supranuclear gaze deficits, parkinsonism (bradykinesia, rigidity, lack of tremor, frequent falls)
  • Pseudobulbar palsy, dysphagia, dysarthria
  • Subcortical dementia (prominent executive dysfunction)
  • Language impairment (echolalia, palilalia)
  • Imaging - atrophy of pons, midbrain
  • Pathology - neurofibrillary tangles in residual midbrain neurons, cortex and cerebellum spared, pons and midbrain atrophy
A

Progressive supranuclear palsy

steele-richardson-olszewski syndrome

24
Q

What are the supranuclear gaze deficits found in supranuclear palsy?

A
  1. downgaze then upgaze palsy
  2. vertical then horizontal involvement
  3. apraxia of eyelid opening
25
Q

Diagnosis?

  • Onset > 70, M=F; survival 5-10 year
  • Clinical, asymmetrical; unilateral onset
  • Extrapyramidal rigidity (akinetic rigidity), action and postural tremor, apraxia and “alien hand syndrome” of UE
  • Subcortical dementia
  • Supranuclear gaze palsy
  • Corticospinal tract involvement (increased DTR’s and bilateral babinski)
  • Imaging: MRI - asymmetric parietal lobe atrophy (CL to limb), PET - decreased metabolism in thalamoparietal and medial frontal areas
  • Pathology - cortical atrophy, neuronal loss and gliosis in parietal and medial frontal lobes CL to involved limb
    • Degeneration of the substantia nigra
    • No Pick bodies, tangles, plaques or Lewy bodies
A

Cortical-Basal Ganglionic Degeneration (CBGD)

26
Q

Diagnosis?

  • AD, chromosome 4 - trinucleotide repeat CAG
  • >40 symptomatic, >60 childhood onset
  • Onset 35-40, M>F
    1. Personality changes, 2. dementia, 3. psychosis
  • Pathophysiology - degeneration of GABA and cholinergic neurons in the striatum
  • Imaging
    • MRI/CT; large boxcar-shaped ventricles with caudate atrophy, cortical atrophy
    • PET: hypometabolism in caudate and putamen
  • Pathology: atrophy of the caudate, putamen, cortex (layer 3)
    • striatum eventually replaced by gliosis
  • Tx. haldol, tetrabenazine, klonopin
A

Huntingon’s Disease

27
Q

Diagnosis?

  • AR, chromosome 13; Onset 11-25
  • Clinical:
      1. subcortical dementia, psychosis
      1. dysphagia, dysarthria, rigidity, tremor
  • Liver involvement with hepatitis/cirrhosis
  • Eyes: KF rings (deposition of Cu in Descemet’s membrane of the cornea), 100% with CNS disease and 75% with liver disease
  • Labs: serum Cu increased, serum ceruloplasm decreased, LFTs
  • Pathophysiology: defect in Cu-binding P-type ATPase with decreased biliary excretion of Cu
  • Imaging: CT - atrophy, hypodensity of basal ganglia
  • Pathology: Opalski cells [large protoplasmic astrocytes]
    • Spongy degeneration and cavitation in putamen
    • Brick red discoloration and atrophy of BG
  • Tx. D-penicillamine, Pyridoxine, or zinc acetate or liver transplant
A

Wilson’s disease

28
Q

What disease?

  • Hypodense regions in the basal ganglia (caudate nucleus, putamen, globus pallidus)
A

Wilson’s disease

29
Q

HIV associated, SSPE, PML, Neurosyphillis, Prion diseases - these are all infections that can cause?

  • HIV : attention/concentration, speed of information processing, abstraction/reasoning, visuospatial skill, memory/learning, speech/language
A

DEMENTIA

30
Q

Diagnosis?

  • Etiology: papovavirus (JC and SV-40)
  • Most common in AIDS patients, hodgkin’s and CLL, patients on Tysabri, Humira (>150 cases)
  • Clinical: dementia, visual loss, progressive hemiparesis
  • Pathology: occipital demyelination, oligodendrocytes contain eosinophilic intranuclear inclusions
  • Tx. vistide, cytarabine, HAART
A

Progressive Multifocal Leukoencephalopathy

31
Q

Diagnosis:

  • Sporadic form - EEG: generalized periodic sharp wave complexes;
  • 14-3-3 protein in the CSF
  • Transverse flair MRI: bilateral anterior basal ganglia high signal
A

CJD

32
Q

How can you differentiate between sporadic CJD vs new variant CJD?

A

Transverse FLAIR MRI:

  • Sporadic: bilateral anterior basal ganglia high signal
  • New Variant: bilateral and symmetrical high signal in the pulvinar nuclei of the thalamus (‘pulvinar sign’)
33
Q

What is the histopathology of Creutzfeldt Jakob disease?

A

Spongiform change in the brain

34
Q

Diagnosis?

  • Multi-infarct dementia - large vessel infarcts
  • Strategic single infarct dementia (PCA, ACA, B thalamic, BF)
  • Small vessel disease with dementia-multiple lacunes (basal ganglia, frontal WM, PVWM = binswanger’s)
  • Hypoperfusion
  • Hemorrhagic dementia
A

Vascular Dementia

35
Q

Diagnosis?

  • At least 2 of the following must be present:
    • HTN, or known systemic vascular disease (CAD, PVD)
    • Evidence of cerebrovascular disease (CVA)
    • Subcortical brain dysfunction (abn. gait, rigidity, neurogenic bladder)
  • Bilateral subcortical leukoaraiosis - attenuation of the white matter on CT/MRI

*** cannot have multiple cortical lesions on CT/MRI or severe dementia

A

Dementia of the Binswanger’s Type

36
Q

Diagnosis?

  • AD, Chromosome 19, notch 3 gene
  • Onset 20-40, death within 30 years
  • CLinical: recurrent strokes, dementia, migraine with aura, depression/mania
  • Labs: skin/muscle biopsy, genetics
  • CT/MRI: hyperintense lesions on T2 in SCWM and BG
A

CADASIL (Cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoenceophalopathy)

37
Q

What should the nutritional workup be in dementia patients?

4!

A
  • Vitamins: B12, B1, D
  • Hypothyroidism - TSH, free T4
  • RPR
  • Paraneoplastic panel